ArticleTaiwan journal of ophthalmology

Reply to comment on: "Advantages of bevacizumab for aggressive posterior retinopathy of prematurity".

Sidney A Schechet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.